C2C Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
1,981
-172
-8% -$20.1K 0.2% 77
2026
Q1
$259K Hold
2,153
0.22% 77
2025
Q4
$227K Buy
+2,153
New +$202K 0.19% 82
2025
Q2
Sell
-2,333
Closed -$209K 87
2025
Q1
$209K Sell
2,333
-25
-1% -$2.33K 0.2% 80
2024
Q4
$235K Sell
2,358
-100
-4% -$10.3K 0.22% 80
2024
Q3
$252K Hold
2,458
0.23% 76
2024
Q2
$304K Hold
2,458
0.3% 67
2024
Q1
$324K Sell
2,458
-3,390
-58% -$418K 0.32% 62
2023
Q4
$636K Sell
5,848
-9,815
-63% -$1.02M 0.54% 46
2023
Q3
$1.6M Hold
15,663
0.23% 46
2023
Q2
$1.65M Sell
15,663
-91
-0.6% -$10.3K 0.22% 48
2023
Q1
$1.79M Buy
15,754
+1,983
+14% +$214K 0.29% 43
2022
Q4
$1.52M Sell
13,771
-1,568
-10% -$160K 0.26% 42
2022
Q3
$1.36M Sell
15,339
-1,379
-8% -$123K 0.27% 46
2022
Q2
$1.54M Sell
16,718
-298
-2% -$26.4K 0.28% 40
2022
Q1
$1.46M Buy
17,016
+391
+2% +$30.8K 0.25% 51
2021
Q4
$1.27M Buy
+16,625
New +$1.32M 0.18% 69

Other funds holding MRK

C2C Wealth Management's MRK Position: Q2 2026 in Review

C2C Wealth Management reduced its Merck (MRK) stake by 8% in Q2 2026, selling an estimated $20.1K and leaving 1,981 shares worth $255K. The position accounts for 0.2% of the portfolio, ranked #77.

C2C Wealth Management first reported a position in MRK in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.79M in Q1 2023. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • C2C Wealth Management held 1,981 shares of Merck worth $255K as of Q2 2026.
  • C2C Wealth Management sold 172 Merck shares in Q2 2026, an estimated $20.1K.
  • Merck made up 0.2% of C2C Wealth Management's portfolio in Q2 2026, its #77 holding.
  • C2C Wealth Management first reported a position in Merck in Q4 2021 and has held it in 17 quarters since.
  • C2C Wealth Management's Merck position peaked at $1.79M in Q1 2023.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on C2C Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.